The University of Southampton
University of Southampton Institutional Repository

A 3D-induced pluripotent stem cell-derived human neural culture model to study certain molecular and biochemical aspects of Alzheimer’s disease

A 3D-induced pluripotent stem cell-derived human neural culture model to study certain molecular and biochemical aspects of Alzheimer’s disease
A 3D-induced pluripotent stem cell-derived human neural culture model to study certain molecular and biochemical aspects of Alzheimer’s disease
Purpose: Alzheimer’s disease (AD) early pathology needs better understanding and models. Here, we describe a human induced pluripotent stem cells (iPSCs)-derived 3D neural culture model to study certain aspects of AD biochemistry and pathology.

Method: iPSCs derived from controls and AD patients with Presenilin1 mutations were cultured in a 3D platform with a similar microenvironment to the brain, to differentiate into neurons and astrocytes and self-organise into 3D structures by 3 weeks of differentiation in vitro.

Results: cells express astrocytic (GFAP), neuronal (β3-Tubulin, MAP2), glutamatergic (VGLUT1), GABAergic (GAD65/67), pre-synaptic (Synapsin1) markers and a low level of neural progenitor cell (Nestin) marker after 6 and 12 weeks of differentiation in 3D. The foetal 3R Tau isoforms and adult 4R Tau isoforms were detected at 6 weeks post differentiation, showing advanced neuronal maturity. In the 3D AD cells, total and insoluble Tau levels were higher than in 3D control cells.

Conclusion: our data indicates that this model may recapitulate the early biochemical and pathological disease features and can be a relevant platform for studying early cellular and biochemical changes and the identification of drug targets.
2731-3441
pages447–462
Prasannan, Preeti
0ae26d12-47e6-43b4-8fa2-9b2b78ee4a6a
Siney, Elodie Jane
b72372cf-c5dd-4303-8836-57562d30953c
Chatterjee, Shreyasi
8794dd52-b2da-42cb-ac03-374fe00214d6
Johnston, David
b41163c9-b9d2-425c-af99-2a357204014e
Shah, Mohammad
16c2c93e-b76e-41e8-91d2-43944c582eec
Mudher, Amritpal
ce0ccb35-ac49-4b6c-92b4-8dd5e78ac119
Willaime-Morawek, Sandrine
24a2981f-aa9e-4bf6-ad12-2ccf6b49f1c0
Prasannan, Preeti
0ae26d12-47e6-43b4-8fa2-9b2b78ee4a6a
Siney, Elodie Jane
b72372cf-c5dd-4303-8836-57562d30953c
Chatterjee, Shreyasi
8794dd52-b2da-42cb-ac03-374fe00214d6
Johnston, David
b41163c9-b9d2-425c-af99-2a357204014e
Shah, Mohammad
16c2c93e-b76e-41e8-91d2-43944c582eec
Mudher, Amritpal
ce0ccb35-ac49-4b6c-92b4-8dd5e78ac119
Willaime-Morawek, Sandrine
24a2981f-aa9e-4bf6-ad12-2ccf6b49f1c0

Prasannan, Preeti, Siney, Elodie Jane, Chatterjee, Shreyasi, Johnston, David, Shah, Mohammad, Mudher, Amritpal and Willaime-Morawek, Sandrine (2022) A 3D-induced pluripotent stem cell-derived human neural culture model to study certain molecular and biochemical aspects of Alzheimer’s disease. In Vitro Models, 1, pages447–462. (doi:10.1007/s44164-022-00038-5).

Record type: Article

Abstract

Purpose: Alzheimer’s disease (AD) early pathology needs better understanding and models. Here, we describe a human induced pluripotent stem cells (iPSCs)-derived 3D neural culture model to study certain aspects of AD biochemistry and pathology.

Method: iPSCs derived from controls and AD patients with Presenilin1 mutations were cultured in a 3D platform with a similar microenvironment to the brain, to differentiate into neurons and astrocytes and self-organise into 3D structures by 3 weeks of differentiation in vitro.

Results: cells express astrocytic (GFAP), neuronal (β3-Tubulin, MAP2), glutamatergic (VGLUT1), GABAergic (GAD65/67), pre-synaptic (Synapsin1) markers and a low level of neural progenitor cell (Nestin) marker after 6 and 12 weeks of differentiation in 3D. The foetal 3R Tau isoforms and adult 4R Tau isoforms were detected at 6 weeks post differentiation, showing advanced neuronal maturity. In the 3D AD cells, total and insoluble Tau levels were higher than in 3D control cells.

Conclusion: our data indicates that this model may recapitulate the early biochemical and pathological disease features and can be a relevant platform for studying early cellular and biochemical changes and the identification of drug targets.

Text
s44164-022-00038-5 - Version of Record
Available under License Creative Commons Attribution.
Download (11MB)

More information

Accepted/In Press date: 20 October 2022
Published date: 14 November 2022

Identifiers

Local EPrints ID: 472690
URI: http://eprints.soton.ac.uk/id/eprint/472690
ISSN: 2731-3441
PURE UUID: 2e123c4a-6211-4148-9dc3-b1be0635906a
ORCID for David Johnston: ORCID iD orcid.org/0000-0001-6703-6014
ORCID for Sandrine Willaime-Morawek: ORCID iD orcid.org/0000-0002-1121-6419

Catalogue record

Date deposited: 14 Dec 2022 17:45
Last modified: 19 Mar 2024 02:41

Export record

Altmetrics

Contributors

Author: Preeti Prasannan
Author: Elodie Jane Siney
Author: Shreyasi Chatterjee
Author: David Johnston ORCID iD
Author: Mohammad Shah
Author: Amritpal Mudher

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×